FDMT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.70%

Insider Buying (Last 12 Months): $13,600,000.00

Insider Selling (Last 12 Months): $15,672,095.74

4D Molecular Therapeutics Insider Trading History Chart

4D Molecular Therapeutics Share Price & Price History

^$23.25

▼ -0.28 (-1.19%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

4D Molecular Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/16/2024	Scott Bizily	Insider	Sell	1,750	$25.74	$45,045.00	1,737
4/1/2024	Scott Bizily	Insider	Sell	8,153	$31.78	$259,102.34	1,737
3/27/2024	Scott Bizily	Insider	Sell	5,833	$35.04	$204,388.32	1,737
3/18/2024	Scott Bizily	Insider	Sell	1,750	$31.27	$54,722.50	1,737
2/27/2024	Scott Bizily	Insider	Sell	1,909	$30.00	$57,270.00	1,737
2/16/2024	Scott Bizily	Insider	Sell	1,750	$27.67	$48,422.50	1,737
2/8/2024	David Kirn	CEO	Sell	92,001	$27.13	$2,495,987.13	1,059,153
2/8/2024	Scott Bizily	Insider	Sell	6,244	$27.50	$171,710.00	1,737
2/5/2024	Robert Young Kim	Insider	Sell	24,552	$30.05	$737,787.60	1,043
1/23/2024	David Kirn	CEO	Sell	5,696	$18.41	$104,863.36	1,151,154
1/4/2024	David Kirn	CEO	Sell	40,732	$20.31	$827,266.92	1,185,087
1/4/2024	Global Investors Lp Viking	Major Shareholder	Sell	540,000	$19.53	$10,546,200.00	4,247,914
6/8/2023	Scott Bizily	Insider	Sell	3,750	$20.85	$78,187.50	1,737
6/1/2023	Scott Bizily	Insider	Sell	2,247	$18.31	$41,142.57	1,737
5/9/2023	Global Investors Lp Viking	Major Shareholder	Buy	850,000	$16.00	$13,600,000.00	4,787,914
4/21/2023	Jacob Chacko	Director	Sell	5,000	$20.05	$100,250.00
4/21/2023	Scott Bizily	Insider	Sell	3,750	$20.00	$75,000.00	2,109
3/1/2023	Scott Bizily	Insider	Sell	2,248	$19.30	$43,386.40	2,109
2/21/2023	David Kirn	CEO	Sell	17,997	$20.96	$377,217.12	1,875,602
1/19/2023	David Kirn	CEO	Sell	10,899	$20.03	$218,306.97	1,902,224
12/15/2022	David Kirn	CEO	Sell	32,933	$23.59	$776,889.47	1,967,067
12/1/2022	Scott Bizily	Insider	Sell	6,000	$22.79	$136,740.00	2,482
10/22/2021	David Schaffer	Director	Sell	1,900	$31.00	$58,900.00
10/20/2021	David Schaffer	Director	Sell	11,565	$31.02	$358,746.30
9/29/2021	David Schaffer	Director	Sell	16,871	$28.61	$482,679.31
9/27/2021	David Schaffer	Director	Sell	19,332	$32.89	$635,829.48

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for 4D Molecular Therapeutics (NASDAQ:FDMT)

99.27% of 4D Molecular Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

4D Molecular Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Assenagon Asset Management S.A.	430,556	$13.72M	0.0%	N/A	0.842%
4/18/2024	Allspring Global Investments Holdings LLC	3,457	$0.11M	0.0%	+702.1%	0.007%
3/5/2024	Wellington Management Group LLP	180,475	$3.66M	0.0%	+4.5%	0.363%
3/1/2024	Goldman Sachs Group Inc.	816,343	$16.54M	0.0%	+415.8%	1.910%
2/14/2024	Sectoral Asset Management Inc.	142,510	$2.89M	1.2%	N/A	0.333%
2/13/2024	Rafferty Asset Management LLC	126,589	$2.57M	0.0%	-21.5%	0.296%
2/9/2024	Franklin Resources Inc.	52,564	$1.07M	0.0%	+266.0%	0.123%
2/8/2024	Panagora Asset Management Inc.	103,671	$2.10M	0.0%	+37.0%	0.243%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	19,835	$0.40M	0.0%	+29.8%	0.046%
2/6/2024	Charles Schwab Investment Management Inc.	268,638	$5.44M	0.0%	+3.9%	0.628%
2/6/2024	Swiss National Bank	41,500	$0.84M	0.0%	-10.0%	0.097%
2/2/2024	Bfsg LLC	1,500	$30K	0.0%	N/A	0.004%
2/1/2024	New York State Common Retirement Fund	19,422	$0.39M	0.0%	+40.6%	0.045%
1/31/2024	Daiwa Securities Group Inc.	5,872	$0.12M	0.0%	+23.3%	0.014%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	5,571	$0.11M	0.0%	-17.7%	0.013%
1/30/2024	Vontobel Holding Ltd.	142,510	$2.89M	0.0%	N/A	0.333%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	21,612	$0.44M	0.0%	+14.3%	0.051%
1/24/2024	DekaBank Deutsche Girozentrale	46,000	$0.97M	0.0%	N/A	0.108%
1/24/2024	China Universal Asset Management Co. Ltd.	4,951	$100K	0.0%	+359.3%	0.012%
1/12/2024	SG Americas Securities LLC	26,899	$0.55M	0.0%	+119.5%	0.063%
12/18/2023	Vanguard Group Inc.	1,902,467	$24.22M	0.0%	-3.6%	4.450%
12/6/2023	Citigroup Inc.	54,699	$0.70M	0.0%	-5.9%	0.128%
12/1/2023	Wellington Management Group LLP	172,722	$2.20M	0.0%	+2.2%	0.404%
11/15/2023	RA Capital Management L.P.	4,163,211	$53M	1.0%	+35.6%	9.739%
11/14/2023	Trexquant Investment LP	44,443	$0.57M	0.0%	N/A	0.106%
11/14/2023	Profund Advisors LLC	21,054	$0.27M	0.0%	-26.8%	0.050%
11/14/2023	Peloton Wealth Strategists	25,000	$0.32M	0.1%	N/A	0.059%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	348,700	$4.44M	0.0%	+4.3%	0.829%
11/13/2023	Aigen Investment Management LP	16,985	$0.22M	0.0%	N/A	0.040%
11/13/2023	Rafferty Asset Management LLC	161,286	$2.05M	0.0%	-18.2%	0.384%
11/9/2023	Citigroup Inc.	54,699	$0.70M	0.0%	-5.9%	0.130%
11/8/2023	State Board of Administration of Florida Retirement System	11,187	$0.14M	0.0%	N/A	0.027%
11/8/2023	Swiss National Bank	46,100	$0.59M	0.0%	-25.2%	0.110%
11/7/2023	Barclays PLC	73,935	$0.94M	0.0%	-48.1%	0.176%
11/7/2023	Fox Run Management L.L.C.	12,162	$0.16M	0.0%	N/A	0.029%
11/6/2023	Privium Fund Management B.V.	33,680	$0.43M	0.1%	N/A	0.080%
11/2/2023	Principal Financial Group Inc.	11,041	$0.14M	0.0%	N/A	0.026%
11/2/2023	M&T Bank Corp	39,481	$0.50M	0.0%	+37.0%	0.094%
10/31/2023	Panagora Asset Management Inc.	75,688	$0.96M	0.0%	N/A	0.180%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	18,912	$0.24M	0.0%	-6.8%	0.045%
10/24/2023	Bank of New York Mellon Corp	135,711	$1.73M	0.0%	+16.7%	0.323%
10/24/2023	Affinity Wealth Management LLC	11,471	$0.15M	0.0%	N/A	0.027%
10/13/2023	SG Americas Securities LLC	12,254	$0.16M	0.0%	N/A	0.029%
10/4/2023	International Assets Investment Management LLC	2,800	$36K	0.0%	N/A	0.007%
8/15/2023	RA Capital Management L.P.	3,069,531	$55.47M	1.0%	N/A	7.300%
8/14/2023	ArrowMark Colorado Holdings LLC	1,031,398	$18.64M	0.2%	-0.1%	2.453%
8/14/2023	Great Point Partners LLC	350,000	$6.32M	1.2%	N/A	0.832%
8/14/2023	Bellevue Group AG	45,000	$0.81M	0.0%	N/A	0.107%
8/14/2023	UniSuper Management Pty Ltd	226,355	$4.09M	0.0%	N/A	0.538%
8/14/2023	Deep Track Capital LP	2,778,107	$50.20M	2.3%	+21.9%	6.607%
8/14/2023	Ghisallo Capital Management LLC	25,000	$0.45M	0.1%	N/A	0.059%
8/11/2023	VR Adviser LLC	3,000,000	$54.21M	8.7%	N/A	9.020%
8/10/2023	Profund Advisors LLC	28,779	$0.52M	0.0%	+14.8%	0.087%
8/10/2023	Elmwood Wealth Management Inc.	19,800	$0.36M	0.2%	N/A	0.060%
8/9/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	14,458	$0.26M	0.0%	+20.1%	0.043%
8/8/2023	Candriam S.C.A.	173,000	$3.13M	0.0%	-26.4%	0.520%
8/4/2023	American International Group Inc.	15,201	$0.28M	0.0%	+5.0%	0.046%
8/3/2023	Barclays PLC	142,464	$2.57M	0.0%	+148.9%	0.339%
8/3/2023	Bank of New York Mellon Corp	116,277	$2.10M	0.0%	+7.2%	0.350%
7/31/2023	Daiwa Securities Group Inc.	4,762	$86K	0.0%	+3,563.1%	0.014%
5/15/2023	Healthcare of Ontario Pension Plan Trust Fund	472,500	$8.12M	0.0%	-38.9%	1.468%
5/12/2023	Sectoral Asset Management Inc.	80,029	$1.38M	0.3%	+48.7%	0.249%
5/12/2023	Profund Advisors LLC	25,079	$0.43M	0.0%	N/A	0.078%
5/11/2023	M&T Bank Corp	28,814	$0.50M	0.0%	+22.4%	0.089%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	48,799	$0.84M	0.0%	+1.2%	0.152%
5/9/2023	Tower Research Capital LLC TRC	8,366	$0.14M	0.0%	+124.4%	0.026%
5/4/2023	Barclays PLC	57,229	$0.98M	0.0%	+65.1%	0.178%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	19,824	$0.34M	0.0%	+34.5%	0.062%
5/2/2023	Amalgamated Bank	3,172	$55K	0.0%	-16.2%	0.010%
4/28/2023	SG Americas Securities LLC	6,275	$0.11M	0.0%	-27.3%	0.019%
4/12/2023	Vontobel Holding Ltd.	80,529	$1.38M	0.0%	+49.6%	0.242%
3/29/2023	Diametric Capital LP	15,554	$0.35M	0.2%	N/A	0.047%
2/13/2023	Peloton Wealth Strategists	37,000	$0.82M	0.4%	-27.5%	0.114%
2/10/2023	Opaleye Management Inc.	330,000	$7.33M	2.5%	-5.9%	1.019%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	48,198	$1.07M	0.0%	N/A	0.149%
2/10/2023	Sectoral Asset Management Inc.	53,836	$1.20M	0.2%	N/A	0.166%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	14,740	$0.33M	0.0%	+17.4%	0.046%
2/9/2023	Denali Advisors LLC	2,000	$44K	0.0%	N/A	0.006%
2/9/2023	Citigroup Inc.	25,816	$0.57M	0.0%	+160.9%	0.080%
2/8/2023	Belpointe Asset Management LLC	1,671	$37K	0.0%	N/A	0.005%
2/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	12,036	$0.25M	0.0%	N/A	0.037%
2/2/2023	SG Americas Securities LLC	8,631	$0.19M	0.0%	-59.4%	0.027%
1/23/2023	Allspring Global Investments Holdings LLC	12,758	$0.28M	0.0%	-39.1%	0.039%
12/13/2022	Perigon Wealth Management LLC	250,475	$2.01M	0.2%	-28.2%	0.773%
11/15/2022	Peloton Wealth Strategists	51,000	$0.41M	0.2%	+66.6%	0.157%
11/14/2022	Point72 Asset Management L.P.	299,000	$2.40M	0.0%	N/A	0.923%
11/14/2022	PDT Partners LLC	18,719	$0.15M	0.0%	N/A	0.058%
11/8/2022	New York State Common Retirement Fund	19,661	$0.16M	0.0%	+102.6%	0.061%
11/3/2022	Barclays PLC	11,376	$91K	0.0%	+18.3%	0.035%
10/31/2022	SG Americas Securities LLC	21,237	$0.17M	0.0%	+38.7%	0.066%
10/26/2022	Allspring Global Investments Holdings LLC	20,948	$0.17M	0.0%	N/A	0.065%
8/11/2022	Perigon Wealth Management LLC	348,746	$2.43M	0.2%	-37.4%	1.080%
8/11/2022	Eagle Health Investments LP	261,423	$1.83M	0.4%	+97.9%	0.809%
8/11/2022	Trexquant Investment LP	50,780	$0.35M	0.0%	N/A	0.157%
8/11/2022	Alps Advisors Inc.	19,155	$0.13M	0.0%	N/A	0.059%
8/9/2022	Swiss National Bank	64,600	$0.45M	0.0%	+13.3%	0.200%
8/8/2022	Walleye Capital LLC	28,068	$0.20M	0.0%	N/A	0.087%
8/5/2022	M&T Bank Corp	51,108	$0.36M	0.0%	+90.2%	0.158%
7/29/2022	SG Americas Securities LLC	15,309	$0.11M	0.0%	+83.5%	0.047%
6/30/2022	Amalgamated Bank	3,495	$53K	0.0%	N/A	0.011%

Data available starting January 2016

4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company, develops genetic medicines using its therapeutic vector evolution platform in the Netherland and the United States. The company develops a portfolio of genetic medicine product candidates focuses in three therapeutic areas for ophthalmology, cardiology, and pulmonology. Its product pipeline includes 4D-150, which is in phase 1/2 clinical trial for the treatment of wet age-related macular degeneration; and is in phase 1/2 clinical trial for the treatment of diabetic macular edema. The company develops 4D-125, which is in phase 1/2 clinical trial for the treatment of x-linked retinitis pigmentosa; 4D-110, which is in phase 1/2 clinical trial for the treatment of choroideremia; 4D-710, which is in phase 1/2 clinical trial for the treatment cystic fibrosis lung disease; and 4D-310 to treat fabry disease cardiomyopathy and is in phase 1/2 clinical trial. In addition, its product candidates comprises 4D-175, which is in pre-clinical development for the treatment for geographic trophy; and 4D-725 to treat alpha-1 antitrypsin deficiency lung disease and is in pre-clinical development. The company has collaboration and licensing agreements with Arbor Biotechnologies, Inc.; Astellas Gene Therapies, Inc; uniQure biopharma B.V.; and Cystic Fibrosis Foundation. 4D Molecular Therapeutics, Inc. was founded in 2013 and is headquartered in Emeryville, California.

Today's Range

Now: $23.25

$22.75

$23.86

50 Day Range

MA: $28.60

$23.25

$35.87

52 Week Range

Now: $23.25

$9.44

$36.25

Volume

322,774 shs

Average Volume

1,032,310 shs

Market Capitalization

$1.19 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.87

Who are the company insiders with the largest holdings of 4D Molecular Therapeutics?: 4D Molecular Therapeutics' top insider shareholders include:
Global Investors Lp Viking (Major Shareholder)
David Kirn (CEO)
Scott Bizily (Insider)
Robert Young Kim (Insider)
Jacob Chacko (Director)
Learn More about top insider investors at 4D Molecular Therapeutics.
Who are the major institutional investors of 4D Molecular Therapeutics?: 4D Molecular Therapeutics' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.84%
Allspring Global Investments Holdings LLC — 0.01%
Learn More about top institutional investors of 4D Molecular Therapeutics stock.
Which institutional investors are buying 4D Molecular Therapeutics stock?: During the last quarter, FDMT stock was bought by institutional investors including:
Assenagon Asset Management S.A.
Allspring Global Investments Holdings LLC